HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Harbin Pharmaceutical Group Co., Ltd.

http://en.hayao.com/

Latest From Harbin Pharmaceutical Group Co., Ltd.

GNC’s Bankruptcy Targets Sale To Harbin Pharma, With Reorganization Also An Option

Chapter 11 bankruptcy protection filing positions largest shareholder Harbin Pharmaceutical to acquire full ownership for $760m. But petition also gives it an option of reorganizing with $525m financing if a sale is not completed within 141 days.

Dietary Supplements Commercial

GNC Missed Opportunities To Drive Growth On Changing Trends

Jefferies analysts point out more sales of supplements, particularly sports nutrition products, already were moving online before COVID-19 prompted quarantine orders and spike e-commerce sales. GNC could have capitalized but didn’t have capital available to make its online sales platform and operations large enough to support potential growth.

Financing Dietary Supplements

Bankruptcy Filing Could Be GNC's Next Step

Payment is due on 16 May to reduce GNC's debt of more than $865m in convertible notes and other credit facilities to less than $50m. "Substantial doubt exists regarding our ability to reduce the" debt to less than $50m, says CFO Tricia Tolivar.

Financing Sales & Earnings

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

Dietary Supplements Sales & Earnings
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Vaccines
  • Other Names / Subsidiaries
    • Harbin Pharmaceutical Group Holding Co Ltd
    • HPGC Medical Co., Ltd.
    • Sanjing Pharmaceutical Co Ltd.
UsernamePublicRestriction

Register